Literature DB >> 24713850

Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study.

Rumi Tsukinoki1, Tomonori Okamura2, Makoto Watanabe3, Yoshihiro Kokubo4, Aya Higashiyama5, Kunihiro Nishimura6, Misa Takegami6, Yoshitaka Murakami7, Akira Okayama8, Yoshihiro Miyamoto4.   

Abstract

BACKGROUND: Blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) are risk factors for coronary artery disease (CAD) and ischemic stroke. However, the hazards of their coexistence are not fully understood in Asian populations. We investigated whether the relationship between BP and cardiovascular disease (CVD) outcomes are modified by LDL-C level in a Japanese population.
METHODS: Individuals aged 30-79 years (n = 5,151) were classified into 6 groups according to LDL-C levels (<140 and ≥140mg/dL or lipid medication) and BP levels (optimal BP, prehypertension, and hypertension; reference: low LDL-C and optimal BP). Hazard ratios (HRs) were calculated after adjusting for age, high-density lipoprotein cholesterol, diabetes, smoking status, and alcohol consumption. The effect modification of LDL-C on BP-CVD association was assessed using likelihood ratio tests.
RESULTS: There were 264 CAD and 215 ischemic stroke events during 13 years of follow-up. With low LDL-C, the HRs of prehypertension and hypertension for CAD were 2.01 and 4.71, respectively. Similar trends of HRs were observed with high LDL-C (optimal BP = 2.09, prehypertension = 3.45, hypertension = 5.94). However, the HRs for ischemic stroke did not differ between normal and high LDL-C levels at the same BP level. The apparent effect modification of LDL-C was not observed in the BP-CVD association in either CAD (P = 0.48) or ischemic stroke (P = 0.39).
CONCLUSIONS: The HRs for CAD in prehypertensive and hypertensive groups were higher than those in the optimal BP group at the same LDL-C levels in a Japanese population; however, there was no statistical effect modification of LDL-C on the BP-CAD association. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Asian; Suita Study.; blood pressure; cohort study; coronary artery disease; hypertension; incidence; ischemic stroke; low-density lipoprotein cholesterol

Mesh:

Substances:

Year:  2014        PMID: 24713850      PMCID: PMC4263939          DOI: 10.1093/ajh/hpu059

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  29 in total

1.  The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.

Authors:  Yoshihiro Kokubo; Tomonori Okamura; Makoto Watanabe; Aya Higashiyama; Yuu Ono; Yoshihiro Miyamoto; Yoko Furukawa; Kei Kamide; Katsuyuki Kawanishi; Akira Okayama; Yasunao Yoshimasa
Journal:  Hypertens Res       Date:  2010-10-07       Impact factor: 3.872

2.  Association with serum gamma-glutamyltransferase levels and alcohol consumption on stroke and coronary artery disease: the Suita study.

Authors:  Aya Higashiyama; Ichiro Wakabayashi; Yuu Ono; Makoto Watanabe; Yoshihiro Kokubo; Akira Okayama; Yoshihiro Miyamoto; Tomonori Okamura
Journal:  Stroke       Date:  2011-04-21       Impact factor: 7.914

3.  Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women.

Authors:  Akira Fujiyoshi; Takayoshi Ohkubo; Katsuyuki Miura; Yoshitaka Murakami; Shin-Ya Nagasawa; Tomonori Okamura; Hirotsugu Ueshima
Journal:  Hypertens Res       Date:  2012-06-28       Impact factor: 3.872

4.  A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study.

Authors:  Tomonori Okamura; Yoshihiro Kokubo; Makoto Watanabe; Aya Higashiyama; Yuu Ono; Kunihiro Nishimura; Akira Okayama; Yoshihiro Miyamoto
Journal:  Atherosclerosis       Date:  2011-03-15       Impact factor: 5.162

5.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

Review 6.  Blood cholesterol level and risk of stroke in community-based or worksite cohort studies: a review of Japanese cohort studies in the past 20 years.

Authors:  Taichiro Tanaka; Tomonori Okamura
Journal:  Keio J Med       Date:  2012

7.  Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.

Authors:  Toshio Kushiro; Kyoichi Mizuno; Noriaki Nakaya; Yasuo Ohashi; Naoko Tajima; Tamio Teramoto; Shinichiro Uchiyama; Haruo Nakamura
Journal:  Hypertension       Date:  2008-12-22       Impact factor: 10.190

8.  Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.

Authors:  Tamio Teramoto; Jun Sasaki; Shun Ishibashi; Sadatoshi Birou; Hiroyuki Daida; Seitaro Dohi; Genshi Egusa; Takafumi Hiro; Kazuhiko Hirobe; Mami Iida; Shinji Kihara; Makoto Kinoshita; Chizuko Maruyama; Takao Ohta; Tomonori Okamura; Shizuya Yamashita; Masayuki Yokode; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2013-05-11       Impact factor: 4.928

9.  Elevated serum creatine kinase predicts first-ever myocardial infarction: a 12-year population-based cohort study in Japan, the Suita study.

Authors:  Makoto Watanabe; Tomonori Okamura; Yoshihiro Kokubo; Aya Higashiyama; Akira Okayama
Journal:  Int J Epidemiol       Date:  2009-06-25       Impact factor: 7.196

10.  Executive summary: Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

View more
  10 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Impact of hypertension on the lifetime risk of coronary heart disease.

Authors:  Tanvir Chowdhury Turin; Tomonori Okamura; Arfan Raheen Afzal; Nahid Rumana; Makoto Watanabe; Aya Higashiyama; Yoko M Nakao; Michikazu Nakai; Misa Takegami; Kunihiro Nishimura; Yoshihiro Kokubo; Akira Okayama; Yoshihiro Miyamoto
Journal:  Hypertens Res       Date:  2016-03-10       Impact factor: 3.872

3.  Association of polymorphisms in the MAFB gene and the risk of coronary artery disease and ischemic stroke: a case-control study.

Authors:  Qian Yang; Rui-Xing Yin; Yi-Jiang Zhou; Xiao-Li Cao; Tao Guo; Wu-Xian Chen
Journal:  Lipids Health Dis       Date:  2015-07-25       Impact factor: 3.876

4.  Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy.

Authors:  Qing-Hui Zhang; Rui-Xing Yin; Wu-Xian Chen; Xiao-Li Cao; Yu-Ming Chen
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

5.  ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses.

Authors:  Qian Yang; Rui-Xing Yin; Xiao-Li Cao; Feng Huang; Yi-Jiang Zhou; Wu-Xian Chen
Journal:  Nutr Metab (Lond)       Date:  2018-10-05       Impact factor: 4.169

6.  Short-Term Consumption of Cuban Policosanol Lowers Aortic and Peripheral Blood Pressure and Ameliorates Serum Lipid Parameters in Healthy Korean Participants: Randomized, Double-Blinded, and Placebo-Controlled Study.

Authors:  Hye-Jeong Park; Dhananjay Yadav; Da-Jeong Jeong; Suk-Jeong Kim; Myung-Ae Bae; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  Int J Environ Res Public Health       Date:  2019-03-05       Impact factor: 3.390

7.  Association of lipid markers with coronary heart disease and stroke mortality: A 15-year follow-up study.

Authors:  Bagher Pahlavanzade; Farid Zayeri; Taban Baghfalaki; Omid Mozafari; Davood Khalili; Fereidoun Azizi; Alireza Abadi
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

8.  Factors associated with elevated low-density lipoprotein cholesterol levels among hill tribe people aged 30 years and over in Thailand: a cross-sectional study.

Authors:  Niwed Kullawong; Tawatchai Apidechkul; Panupong Upala; Ratipark Tamornpark; Vivat Keawdounglek; Chanyanut Wongfu; Fartima Yeemard; Siriyaporn Khunthason; Chalitar Chomchoei
Journal:  BMC Public Health       Date:  2021-03-12       Impact factor: 3.295

9.  No Association Between Single-Nucleotide Polymorphism 56 (SNP56) in Phosphodiesterase 4D (PDE4D) Gene and Susceptibility to Ischemic Stroke: A Meta-Analysis of 15 Studies.

Authors:  Xin-Yong Zhang; Qi Wan; Dong-Ya Zhu
Journal:  Med Sci Monit       Date:  2016-10-19

10.  A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH-JAPAN.

Authors:  Michihiro Satoh; Takayoshi Ohkubo; Kei Asayama; Yoshitaka Murakami; Daisuke Sugiyama; Takashi Waki; Sachiko Tanaka-Mizuno; Michiko Yamada; Shigeyuki Saitoh; Kiyomi Sakata; Fujiko Irie; Toshimi Sairenchi; Shizukiyo Ishikawa; Masahiko Kiyama; Akira Okayama; Katsuyuki Miura; Yutaka Imai; Hirotsugu Ueshima; Tomonori Okamura
Journal:  J Atheroscler Thromb       Date:  2020-04-08       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.